@article{4c64946576e74db3a77639d4a0e6e5d0,
title = "Social & psychological factors associated with oral analgesic use in knee osteoarthritis management",
abstract = "Objective: Determine modifiable social and psychological health factors that are associated with use of oral opioid and non-opioid medications for OA. Methods: Patients were categorized based on use of the following oral medications: opioids (with/without other oral analgesic treatments), non-opioid analgesics, and no oral analgesic treatment. We used multinomial logistic regression models to estimate adjusted relative risk ratios (RRRs) of using an opioid or a non-opioid analgesic (vs. no oral analgesic treatment), comparing patients by levels of social support (Medical Outcomes Study scale), health literacy (“How confident are you filling out medical forms by yourself?”), and depressive symptoms (Patient Health Questionnaire-8). Models were adjusted for demographic and clinical characteristics. Results: In this sample (mean age 64.2 years, 23.6% women), 30.6% (n = 110) reported taking opioid analgesics for OA, 54.2% (n = 195) reported non-opioid use, and 15.3% (n = 55) reported no oral analgesic use. Opioid users had lower mean social support scores (10.0 vs 10.5 vs 11.9, P = 0.007) and were more likely to have moderate-severe depressive symptoms (42.7% vs 24.1% vs 14.5%, P < 0.001). Health literacy did not differ by treatment group type. Having moderate-severe depression was associated with higher risk of opioid analgesic use compared to no oral analgesic use (RRR 2.96, 95%CI 1.08–8.07) when adjusted for sociodemographic and clinical factors. Neither social support nor health literacy was associated with opioid or non-opioid oral analgesic use in fully adjusted models. Conclusions: Knee OA patients with more severe depression symptoms, compared to those without, were more likely to report using opioid analgesics for OA.",
keywords = "Depression, Health literacy, Osteoarthritis, Social support, Treatment, Utilization",
author = "Vina, {E. R.} and Hausmann, {L. R.M.} and Obrosky, {D. S.} and A. Youk and Ibrahim, {S. A.} and Weiner, {D. K.} and Gallagher, {R. M.} and Kwoh, {C. K.}",
note = "Funding Information: This work was supported by the Veterans Health Administration Health Services Research and Development Service (IIR13-080; Principal Investigator: Dr. Hausmann). Dr. Vina was supported in part by a K23 Career Development Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, K23AR067226). Dr. Ibrahim was supported in part by a K24 Mid-Career Development Award from the NIAMS (K24AR055259). The views expressed here are those of the authors and do not represent those of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institutes of Health, or the United States Government. Funding Information: This work was supported by the Veterans Health Administration Health Services Research and Development Service (IIR13-080; Principal Investigator: Dr. Hausmann). Dr. Vina was supported in part by a K23 Career Development Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases ( NIAMS , K23AR067226 ). Dr. Ibrahim was supported in part by a K24 Mid-Career Development Award from the NIAMS ( K24AR055259 ). The views expressed here are those of the authors and do not represent those of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institutes of Health, or the United States Government. Funding Information: This work was supported by the Veterans Health Administration Health Services Research and Development Service (IIR13-080; Principal Investigator: Dr. Hausmann). Dr. Vina was supported in part by a K23 Career Development Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, K23AR067226). Dr. Ibrahim was supported in part by a K24 Mid-Career Development Award from the NIAMS (K24AR055259). The views expressed here are those of the authors and do not represent those of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institutes of Health, or the United States Government. The authors would like to thank all Staying Positive With Arthritis study staff and participants. Funding Information: None of the authors declare any potential conflicts of interest in regard to this manuscript. Potential conflicts outside of this work: CKK has received grants from Abbvie and EMD Serono and consulted for Astellas, EMD Serono, Thusane, Express Scripts and Novartis. Publisher Copyright: {\textcopyright} 2019 Osteoarthritis Research Society International",
year = "2019",
month = jul,
doi = "10.1016/j.joca.2019.01.010",
language = "English (US)",
volume = "27",
pages = "1018--1025",
journal = "Osteoarthritis and Cartilage",
issn = "1063-4584",
publisher = "W.B. Saunders Ltd",
number = "7",
}